pharmaphorum

OCTOBER 30, 2022

Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote. Changes in standard and supportive care over the time period could also have skewed the results, said the FDA reviewer.

FDA 52

FDA Documentation Labelling Immunization 52

The Thyroid Pharmacist

JULY 14, 2023

TGF-β modulates inflammation and helps to induce and maintain the “tolerance of self” (which means the immune system is more capable of recognizing itself and less likely to attack itself), thus also reducing thyroid autoimmunity. This Class II medical device is FDA-cleared and meant to target all kinds of pain.

Dosage 98

Dosage FDA Immunization Documentation 98

The Thyroid Pharmacist

JUNE 14, 2023

Both are tied to autoimmune processes in the body, when the immune system begins to recognize different parts of the thyroid gland as foreign invaders. A 2015 case report documented the thyroid labs of a man who had recurrent hyperthyroid episodes after three of his wife’s pregnancies! His wife had Hashimoto’s.)

Health and Personal Care Stores 109

Health and Personal Care Stores Immunization Documentation Compounding 109